MedPath
NMPA Approval

Tofacitinib Citrate Sustained-release Tablets

国药准字H20234125

September 5, 2023

Drug Information

枸橼酸托法替布缓释片

片剂

11mg(按C₁₆H₂₀N₆O计)

化学药品

September 5, 2023

Company Information

Applicant Company

浙江省台州市椒江区滨海路27号

Manufacturing Company

浙江省台州市椒江区滨海路27号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

枸橼酸托法替布缓释片 - NMPA 批准文号 | MedPath